Switch to
More onapp

Bafna Pharmaceuticals Ltd

BAFNAPH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹234 cr, stock is ranked 1,687
Moderate RiskStock is 2.46x as volatile as Nifty
101.952.90 (+2.93%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹234 cr, stock is ranked 1,687
Moderate RiskStock is 2.46x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
45.50
PB RatioPB Ratio
3.73
Dividend YieldDiv. Yield
Sector PESector PE
34.97
Sector PBSector PB
4.27
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bafna Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in the manufacture of drugs and medicines.

Financial TrendFinancial statements 

201920202021202244.0242.7371.9787.24-19.73-25.205.835.15
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General updates 
Announced OnSep 28, 2022

Bafna Pharmaceuticals Limited has informed the Exchange about Sale Of Equity Shares Of The Company By SRJR Life Science LLP Through Open Market Sale For acheiving Minimum Public Shareholding. | Download

Bafna Pharmaceuticals Limited has informed the Exchange about Sale Of Equity Shares Of The Company By SRJR Life Science LLP Through Open Market Sale For acheiving Minimum Public Shareholding. | Download

Resignation 
Announced OnAug 11, 2022

Bafna Pharmaceuticals Limited has informed the Exchange about resignation of ROOPA RAVIKUMAR as Company Secretary and compliance officer of the company w.e.f. 11-Aug-2022 | Download

Bafna Pharmaceuticals Limited has informed the Exchange about resignation of ROOPA RAVIKUMAR as Company Secretary and compliance officer of the company w.e.f. 11-Aug-2022 | Download

Cash Dividend 
Ex. DateSep 19, 2013

Final • Div/Share: ₹ 0.6

See all events